Recent public signals classified as Short Seller, with first-party permanent pages for source and price-impact review.
Investors face a securities-law investigation into Gildan Activewear after Jehoshaphat Research alleged revenue inflation via channel stuffing and a $510 million distributor inventory overhang. The controversy triggered a stock decline and raises questions about earnings quality and demand. The investigation could keep near-term volatility until credible updates emerge.
View signal analysisJohnson Fistel, a securities-law firm, is investigating Blaize Holdings (BZAI) after two late-April short-seller reports questioned customer agreements and a NeoTensr deal with a $50 million revenue target. The stock fell sharply after the reports, highlighting potential legal and reputational risks. Investors should watch for any formal regulatory actions, settlements, or disclosures that could materially affect BZAI’s valuation and liquidity.
View signal analysisADMA Biologics faced a 16% stock drop after allegations of financial misconduct surfaced. Hagens Berman is investigating potential violations of securities laws, which could severely impact investor confidence and ADMA's financials.
View signal analysisCapitalWatch's retraction of accusations against AppLovin shareholder Hao Tang mitigates reputational risks. However, the short-seller's stance on AppLovin's financials remains unchanged, potentially leading to continued scrutiny. This may impact investor confidence in the near term but does not diminish the stock's recent performance.
View signal analysisCarvana's stock dropped 14.2% after short-seller Gotham City Research accused it of overstating earnings by over $1 billion. This raises concerns over its financial credibility and relationship with family-controlled businesses, potentially leading to further volatility in its stock price in the near term.
View signal analysisAppLovin is currently under scrutiny due to a report from CapitalWatch alleging ties to criminal activities through its major shareholder. The company has countered these claims with a cease and desist letter, which could lead to legal implications and impact investor sentiment moving forward.
View signal analysis